Core Viewpoint - Boston Scientific Corporation (BSX) reported strong first-quarter 2025 results, with adjusted earnings per share (EPS) of 75 cents, a 33.9% increase year-over-year, surpassing both the Zacks Consensus Estimate and the company's own guidance range [1][3][11] Financial Performance - The first-quarter revenue reached $4.66 billion, reflecting a 20.9% year-over-year increase on a reported basis and 22.2% on an operational basis, exceeding the Zacks Consensus Estimate by 2.3% [3][11] - Reported EPS for the quarter was 45 cents, marking a 36.4% increase from the previous year [2] Revenue Breakdown - Revenue growth by region included a 31.1% increase in the United States, 5.5% in EMEA, 8.2% in Asia Pacific, and 4.4% in Latin America and Canada [4] - Emerging markets saw a reported revenue growth of 6.5% [4] Segment Performance - MedSurg segment revenues were $1.58 billion, up 11.7% year-over-year, with notable contributions from Endoscopy ($673 million), Urology ($633 million), and Neuromodulation ($271 million) [6] - Cardiovascular segment revenues reached $3.09 billion, a 26.2% increase, with Cardiology business sales totaling $2.43 billion, up 31.2% [7] Margin Analysis - Gross margin expanded by 19 basis points to 68.8%, while adjusted operating margin increased by 127 basis points to 24.8% [8] Future Outlook - For 2025, BSX anticipates net sales growth of approximately 15-17% on a reported basis and 12-14% on an organic basis, with adjusted EPS expected in the range of $2.87-$2.94 [9][10] - The second quarter of 2025 is projected to see revenue growth of 17.5-19.5% on a reported basis [10] Strategic Developments - Recent acquisitions include SoniVie Ltd. and Bolt Medical, which are expected to positively impact the company's growth trajectory [12]

这个周末我摄入的信息里，最有意思的是金沙创投朱啸虎的一篇采访，它起了一个比较醒目的标题：《我们正批量退出人形机器人公司》。 朱啸虎在创投圈名声很响，因为他不但投的准，压中了多个独角兽，更难得的是他卖的也挺准。他最著名的两个案例是滴滴和小黄车ofo，早期进 入，然后中间在估值高峰期果断退出股份，先后避开了网约车的政策转向，以及共享单车的行业大崩盘。 就是这么一个人，说目前批量退出人形机器人公司，让我很感兴趣他是怎么思考的。 朱啸虎的理由主要是两个： 人型机器人商业化路径不清晰 缺乏真实可持续的客户需求，现有客户多为高校研究机构、竞争对手或展示用途（如央企购买作前台展示），并非可持续的商 业化场景。 市场共识过高 行业估值因市场情绪快速上涨，但商业化能力未得到验证，多年从业经验告诉他这种时候该撤了。 说白了一句话，就是这些机器人公司估值涨太多了，但是又没想好怎么挣钱。 大致就这些，诸位也不必过于在乎他的观点，我前面没说朱啸虎也有不成功的交易，他卖小红书就卖的太早，踏空了后面巨大的利润空间。他这 次抛出的观点可以作为参考，尤其是现在全市场对人型机器人几乎全是溢美之词，很难看到泼冷水的话。 他提到的那两点，起码市场共 ...